Project Grant HT94252510599
Award Date
6/15/25
Completion Date
6/14/29
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This $1,005,000.00 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research on mast cell therapy for ovarian cancer at Yale University. The award, with a period of performance from June 15, 2025 to June 14, 2029, will fund advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant supports Yale University's work in...
The Department of the Army Medical Command awarded Yale University a $1,304,470.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, supports the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER" over a performance period ending on June 30, 2029. This research project aims to develop a novel class of universal cellular immunotherapies for the...
The federal Project Grant award in the amount of $705,038.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER" at Yale University over the period of July 1, 2025 to June 30, 2029. This research project aims to develop innovative cellular immunotherapies for the treatment of ovarian cancer, a...
This $460,279 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University to investigate the "Loss of Proteostasis and Vascular Amyloidosis". The research, conducted from February 2025 to February 2027, aims to transform healthcare for military service members and the general public through innovative and impactful research. Yale University is a...
The Defense Health Agency awarded Yale University a $3,129,087.00 Project Grant on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced research to develop integrative platforms for cellular immunotherapies against resistant hematopoietic malignancies and solid tumors. Key aims include targeting combinations of gene editing and CAT inhibition to enhance CAR-T cell function, and investigating gene editing coupled with CAT...
The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This $859,773 federal Project Grant was awarded on May 1, 2025 by the Defense Health Agency to Yale University under the Military Medical Research and Development (CFDA 12.420) program. The funding will support a 3-year research project focused on investigating biomarkers and targets related to the progression of leptomeningeal disease from non-small cell lung cancer brain metastasis. The award enables Yale University to conduct advanced biomedical research that aims to transform healthcare...
The Defense Health Agency awarded Yale University a $837,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MECHANISM-CENTRIC PREDICTIVE MODELING FOR PROSTATE CANCER". The 3-year grant, running from July 1, 2024 to June 30, 2027, supports Yale's work to develop new predictive modeling approaches for prostate cancer. This research aims to improve understanding of the underlying biological mechanisms driving prostate cancer...
This federal Project Grant award of $837,497.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research by Yale University to investigate "FEEDING STRESS PRIMES THE PANCREAS FOR CANCER" with a performance period from November 1, 2024 to October 31, 2027. The research aims to transform healthcare for military service members and the broader public by exploring innovative...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...